Congress date
June 24–26, 2022
We took a 360° view on the exciting new developments in the field of Theranostics and Radiomolecular Precision Medicine (RPM).
June 24–26, 2022
RheinMain Congress Center
Wiesbaden, Germany
Prof. Dr. Richard P. Baum
Prof. Dr. Frank Rösch,
Elcin Zan, New York, United States
Dear colleagues and friends
At the closing session of the 5th Theranostics World Congress (TWC) 2019 in Jeju, South Korea, we announced that the 6th TWC would be held in Santiago, Chile, in March 2021, symbolized by the traditional handover of the TWC trophy.
Pandemic changed our plans and unfortunately, we had to postpone the TWC-2021. Then came the vaccines, giving a fresh breath back to life and enabling us to connect in-person again. We remain deeply convinced that this meeting should be held face-to-face, facilitating the exchange of ideas, networking, and sparking discussions in the same familiar environment as before. Therefore, it is my great pleasure and honor to welcome you to Wiesbaden for the 6th TWC – but also offer the opportunity to participate virtually.
Wiesbaden is one of the few towns not heavily damaged during the world war and has a lot to offer in history, arts, food including beautiful architecture (e.g., the famous Kurhaus and Theater) as well as Michelin-rated restaurants. The brand-new Rhein-Main Congress Center (RMCC) – located just 20 minutes from Frankfurt airport – will host us during this long-awaited gathering. After breathtaking science, you have the opportunity to relax during a very special evening on June 24th at Kloster (Abbey) Eberbach which is a former Cistercian monastery in Eltville in the Rheingau (the movie version of “The Name of the Rose” brought it to world’s attention).
Please allow us to say, after more than 10 years – the first TWC took place in Bad Berka in 2011 – we are still at the beginnings of the extremely exciting field of Theranostics and Radiomolecular Precision Oncology. But, since the last TWC in 2019, we have witnessed an outstanding growth of Theranostics with an exponential increase in publications, clinical indications, introduction of promising novel radioisotopes and – most importantly – new treatment concepts empowered by patient advocates. Here are just a few recent milestones that we would like to share during the congress:
2022 is the celebration of 25 years of Peptide Receptor Radionuclide Therapy (PRRT) in Germany which started in Frankfurt/Main in 1997.
There is certainly a lot to learn, discuss and celebrate! Therefore, it’s our great pleasure to invite you to the 6th Theranostic World Congress from June 24 – 26, 2022, in Wiesbaden; the 7th TWC will follow in March 2024, in Santiago, Chile.
Yours sincerely,
Richard P. Baum, Frank Rösch, Vasko Kramer and Horacio Amaral
The need for global standardization
And much more ...
In 2022 abstracts could be submitted for one of the following topics. The best abstracts were honored with the poster awards.
Advances in Radiochemistry & Radioisotope Production
Clinical Applications
Highlights in Preclinical R&D
Nuclear Medicine meets Genetics
Other/Various
The best three submitted Abstracts in recognition of outstanding work in Radiomolecular Precision Medicine were honored as part of the 6th Theranostic World Congress (TWC).
Dr. Ralf Bergmann, Dresden, Germany
Michiel Van de Voorde, Mol, Belgium
Friedmund Bachmann, Vienna, Austria
As part of the 6th Theranostic World Congress (TWC) the ICPO Foundation proudly launches the 1st Maurits W. Geerlings Next Generation Award for Outstanding Research and Contributions to Actinium-225 related sciences extending to Theranostics. The award is endowed with EUR 5,000.
Dr. Madhav Prasad Yadav
Department of Nuclear Medicine, AIIMS, New Delhi
Prof. Dr. Mike Sathekge
Head of Nuclear Medicine at University of Pretoria and Steve Biko Academic Hospital, South Africa, current president of WARMTH and Member of the Scientific Advisory Board of the ICPO Foundation
5,000 EUR
one
annually
ITM AG, Munich
The Saul Hertz Young Investigator Award honors outstanding achievement and excellence of early-career professionals in the field of theranostics and was presented at the congress by Barbara Hertz on June 24, 2022.
Prof. Dr. Susanne Kossatz
Department of Nuclear Medicine and Central Institute for Translational Cancer Research (TranslaTUM) at Klinikum rechts der Isar, TU Munich
Prof. Dr. Jingjing Zhang
Department of Diagnostic Radiology; Clinical Imaging Research Centre, Centre for Translational Medicine; Yong Loo Lin School of Medicine | National University of Singapore (NUS)
5,000 EUR
one
biannually
ICPO Foundation
The Thomas O’Dorisio Young Investigator Award in NETs honors outstanding research and scientific contributions in the field of neuroendocrine tumors (especially related to Lead-212 and other alpha and beta emitters) extending to theranostics. The award will be presented by Michael K. Schultz, PhD on June 24, 2022.
A/Prof. Dr. Jingjing Zhang, MBBS, M.D., Ph.D.
Department of Diagnostic Radiology; Clinical Imaging Research Centre, Centre for Translational Medicine; Yong Loo Lin School of Medicine | National University of Singapore (NUS)
Prof. Jason Lewis, PhD (New York, USA)
Emily Tow Jackson Chair in Oncology; Vice Chair for Research, Department of Radiology; Chief, Radiochemistry and Imaging Sciences Service; Director of the Radiochemistry and Molecular Imaging Probe Core Facility | Memorial Sloan Kettering Cancer Center
5,000 EUR
one
annually
Viewpoint Molecular Targeting, Inc. (Coralville, USA)